Anna Kanci

Anna Kanci

Auto-generated profile, based on publicly available information

Anna Kanci

Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Science, The University of Melbourne

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2000 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
ANAmir H Noormohamamdi
Amir H Noormohamamdi
PMP. F. Markham
P. F. Markham
AKA. Kanci
A. Kanci
KWK. G. Whithear
K. G. Whithear
Glenn BrowningGlenn Browning
Glenn Browning
High‐frequency phase and antigenic variation of homologous lipoprotein haemagglutinins has been seen in both the major avian mycoplasma pathogens, Mycoplasma synoviae and Mycoplasma gallisepticum. The expression and, hence, antigenic variation of the pMGA gene family (encoding these lipoproteins in M. gallisepticum) is controlled by variation in the length of a trinucleotide repeat motif 5′ to the promoter of each gene. However, such a mechanism was not detected in preliminary observations on M. synoviae. Thus, the basis for control of variation in the vlhA gene family (which encodes the homologous haemagglutinin in M. synoviae) was investigated to enable comparison with its homologue in M. gallisepticum and with other lipoprotein gene families in mycoplasmas. The start point of transcription was identified 119 bp upstream of the initiation codon, but features associated with control of transcription in other mycoplasma lipoprotein genes were not seen. Comparison of three copies of vlhA revealed considerable sequence divergence at the 3′ end of the gene, but conservation of the 5′ end. Southern blot analysis of M. synoviae genomic DNA revealed that the promoter region and part of the conserved 5′ coding sequence occurred as a single copy, whereas the remainder of the coding sequence occurred as multiple copies. A 9.7 kb fragment of the genome was found to contain eight tandemly repeated regions partially homologous to vlhA, all lacking the putative promoter region and the single‐copy 5′ end of vlhA, but extending over one of four distinct overlapping regions of the 3′ coding sequence. Examination of sequential clones of M. synoviae established that unidirectional recombination occurs between the pseudogenes and the expressed vlhA, with duplication of pseudogene sequence and loss of the corresponding region previously seen in the expressed gene. Expression of the 5′ end of two variants of the vlhA gene showed that they differed in their reaction with monoclonal antibodies specific for this region. These data suggest that the control of vlhA antigenic variation in M. synoviae is achieved by multiple gene conversion events using a repertoire of coding sequences to generate a chimeric expressed gene, with the greatest potential for variation generated in the region encoding the haemagglutinin. Thus, completely distinct mechanisms have been adopted to control antigenic variation in homologous gene families.

11 December 2013 in Clinical and Vaccine Immunology
Verified
Journal Article
Open access
PDF file
NWNadeeka K. Wawegama
Nadeeka K. Wawegama
Glenn BrowningGlenn Browning
Glenn Browning
AKAnna Kanci
Anna Kanci
MMMarc Marenda
Marc Marenda
PMPhilip F. Markham
Philip F. Markham
Mycoplasma boviscauses a range of diseases in cattle, including mastitis, arthritis, and pneumonia. However, accurate serological diagnosis of infection remains problematic. The studies described here aimed to identify an antigen that might be used to develop a more specific and sensitive diagnostic assay. A 226-kDa immunogenic protein was consistently detected in Western blots by antibodies in sera from calves experimentally infected withM. bovis. This protein was shown to be a membrane protein with lipase activity and was named mycoplasma immunogenic lipase A (MilA). Different regions of MilA were expressed inEscherichia colias glutathioneS-transferase (GST) fusion proteins and recombinant products from the amino-terminal end shown to have strong immunoreactivity withM. bovis-specific bovine sera. The most immunoreactive fusion protein, GST-MilA-ab, was used to develop indirect IgM and IgG enzyme-linked immunosorbent assays (ELISAs). The IgM ELISA detectedM. bovis-specific IgM antibody 2 weeks after infection with 97.1% sensitivity and had a specificity of 63.3%, while the IgG ELISA detectedM. bovis-specific IgG 3 weeks after infection with 92.86% sensitivity and had a specificity of 98.7%, demonstrating that the IgG ELISA has potential for use as a sensitive and specific assay for detecting infection in cattle.

1 May 2016 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
NWNadeeka K. Wawegama
Nadeeka K. Wawegama
PMPhilip F. Markham
Philip F. Markham
AKAnna Kanci
Anna Kanci
MSMeghan Schibrowski
Meghan Schibrowski
SOSally Oswin
Sally Oswin
Glenn BrowningGlenn Browning
Glenn Browning
Mycoplasma bovis is a pathogen of emerging significance in cattle throughout the world, causing a range of diseases, including mastitis, arthritis and pneumonia. The limited availability and efficacy of current diagnostic and prophylactic tools for its control, and increasing antimicrobial resistance, are contributing to its increasing importance in beef and dairy cattle. We have developed an indirect IgG ELISA based on a recombinant fragment of the MilA protein and have shown its potential as an effective diagnostic tool. To more comprehensively estimate the diagnostic sensitivity and specificity of this IgG ELISA for detection of infection with M. bovis in cattle and define a suitable cut-off for use in the field, we further assessed its performance in experimentally infected calves, in a closed beef herd and by applying Bayesian latent class modelling to laboratory testing results from 7,448 cattle entering Australian feedlots. The most effective cut-off point was estimated to be 68.6 antibody units (AU) for experimentally infected calves and to be 58.7 AU for a closed adult herd. Under field conditions in feedlot cattle the globally optimal cut-off was estimated to be 105 AU. At this cut-off, the diagnostic sensitivity was 94.3% (95% probability interval [PI]: 89.9, 99.6%), with a diagnostic specificity of 94.4% (95% PI: 90.3, 99.6%). Applying this 105 AU cut-off, 13.1% of cattle were seropositive for infection with M. bovis on entry into feedlots and 73.5% were seropositive when followed up approximately six weeks later, suggesting a high risk of infection shortly after entry into feedlots.

1 October 2017 in Veterinary Microbiology
Verified
Journal Article
Closed access
AKAnna Kanci
Anna Kanci
NWNadeeka K. Wawegama
Nadeeka K. Wawegama
MMMarc Marenda
Marc Marenda
PMPeter Mansell
Peter Mansell
Glenn BrowningGlenn Browning
Glenn Browning
PMPhilip F. Markham
Philip F. Markham

1 June 2011 in Microbiology
Verified
Journal Article
Open access
PSPollob K. Shil
Pollob K. Shil
AKAnna Kanci
Anna Kanci
Glenn BrowningGlenn Browning
Glenn Browning
MMMarc Marenda
Marc Marenda
ANAmir H Noormohamamdi
Amir H Noormohamamdi
PMPhilip F. Markham
Philip F. Markham
Mycoplasma gallisepticum (MG) is an important poultry pathogen that causes respiratory disease and loss of production worldwide, and is currently controlled with live attenuated vaccines. These vaccines have limitations as they vary in their pathogenicity, the protection afforded and their transmissibility, but have been shown to effectively reduce losses associated with challenge in the field. A live attenuated vaccine, ts-11, has been used for the control of M. gallisepticum in several countries. This vaccine is highly dose-dependent and the flock antibody response is weak. GapA is the primary cytadherence molecule in M. gallisepticum, and the absence of GapA expression has been observed in the vast majority of cells in the ts-11 vaccine strain. In this study the immunogenicity of a GapA+ M. gallisepticum ts-11 vaccine was investigated in specific-pathogen-free chickens. Birds vaccinated with GapA+ M. gallisepticum ts-11 were protected against clinical signs of disease following challenge with virulent M. gallisepticum, and GapA+ M. gallisepticum ts-11 was shown to be non-pathogenic and more immunogenic at a lower dose than the currently available M. gallisepticum ts-11 vaccine. Thus, GapA+ M. gallisepticum ts-11 appears to have improved potential as a vaccine candidate.

1 July 2013 in Microbiology
Verified
Journal Article
Open access
PDF file
CTChi-Wen Tseng
Chi-Wen Tseng
AKAnna Kanci
Anna Kanci
CCChristine Citti
Christine Citti
RRRenate Rosengarten
Renate Rosengarten
CCChien-Ju Chiu
Chien-Ju Chiu
PMPhilip F. Markham
Philip F. Markham
There is limited understanding of the molecular basis of virulence in the important avian pathogen Mycoplasma gallisepticum. To define genes that may be involved in colonization of chickens, a collection of mutants of the virulent Ap3AS strain of M. gallisepticum were generated by signature-tagged transposon mutagenesis. The collection included mutants with single insertions in the genes encoding the adhesin GapA and the cytadherence-related protein CrmA, and Western blotting confirmed that these mutants did not express these proteins. In two separate in vivo screenings, two GapA-deficient mutants (ST mutants 02-1 and 06-1) were occasionally recovered from birds, suggesting that GapA expression may not always be essential for persistence of strain Ap3AS. CrmA-deficient ST mutant 33-1 colonized birds poorly and had reduced virulence, indicating that CrmA was a significant virulence factor, but was not absolutely essential for colonization. ST mutant 04-1 contained a single transposon insertion in malF, a predicted ABC sugar transport permease, and could not be reisolated even when inoculated by itself into a group of birds, suggesting that expression of MalF was essential for persistence of M. galliseptium strain Ap3AS in infected birds.